BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 26781105)

  • 1. Τwo-panel molecular testing for genetic predisposition for thrombosis using multi-allele visual biosensors.
    Fountoglou N; Petropoulou M; Iliadi A; Christopoulos TK; Ioannou PC
    Anal Bioanal Chem; 2016 Mar; 408(7):1943-52. PubMed ID: 26781105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of Factor V G1691A, prothrombin G20210A, Factor XIII V34L, MTHFR A1298C, MTHFR C677T and PAI-1 4G/5G genotype frequencies of patients subjected to cardiovascular disease (CVD) panel in south-east region of Turkey.
    Oztuzcu S; Ergun S; Ulaşlı M; Nacarkahya G; Iğci YZ; Iğci M; Bayraktar R; Tamer A; Çakmak EA; Arslan A
    Mol Biol Rep; 2014 Jun; 41(6):3671-6. PubMed ID: 24532105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of thrombophilic genetic mutations in patients with Sheehan's syndrome: is thrombophilia responsible for the pathogenesis of Sheehan's syndrome?
    Gokalp D; Tuzcu A; Bahceci M; Ayyildiz O; Yurt M; Celik Y; Alpagat G
    Pituitary; 2011 Jun; 14(2):168-73. PubMed ID: 21107737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variant alleles in factor V, prothrombin, plasminogen activator inhibitor-1, methylenetetrahydrofolate reductase and risk of thromboembolism in metastatic colorectal cancer patients treated with first-line chemotherapy plus bevacizumab.
    Falvella FS; Cremolini C; Miceli R; Nichetti F; Cheli S; Antoniotti C; Infante G; Martinetti A; Marmorino F; Sottotetti E; Berenato R; Caporale M; Colombo A; de Braud F; Di Bartolomeo M; Clementi E; Loupakis F; Pietrantonio F
    Pharmacogenomics J; 2017 Jul; 17(4):331-336. PubMed ID: 27001121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ABO blood group but not haemostasis genetic polymorphisms significantly influence thrombotic risk: a study of 180 homozygotes for the Factor V Leiden mutation.
    Procare-GEHT Group
    Br J Haematol; 2006 Dec; 135(5):697-702. PubMed ID: 17107352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of genomic polymorphisms associated with venous thrombosis using the invader biplex assay.
    Patnaik M; Dlott JS; Fontaine RN; Subbiah MT; Hessner MJ; Joyner KA; Ledford MR; Lau EC; Moehlenkamp C; Amos J; Zhang B; Williams TM
    J Mol Diagn; 2004 May; 6(2):137-44. PubMed ID: 15096570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cilioretinal artery: Vasculogenesis might be promoted by plasminogen activator inhibitor-1 5G allele.
    Yilmaz S; Ardagil A; Akalin I; Altinel MG; Dag Y; Kurum E; Koyun E; Ari Yaylali S; Bayramlar H
    Ophthalmic Genet; 2017; 38(5):428-433. PubMed ID: 28145780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of genetic polymorphisms and diabetes mellitus on the development of peripheral artery disease.
    Yalım Z; Tutgun Onrat S; Alan S; Aldemir M; Avşar A; Doğan İ; Onrat E
    Turk Kardiyol Dern Ars; 2020 Jul; 48(5):484-493. PubMed ID: 32633259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prevalence of thrombophilic mutations of FV Leiden, prothrombin G20210A and PAl-1 4G/5G and their combinations in a group of 1450 healthy middle-aged individuals in the Prague and Central Bohemian regions (results of FRET real-time PCR assay)].
    Kvasnicka J; Hájková J; Bobcíková P; Kvasnicka T; Dusková D; Poletínová S; Kieferová V
    Cas Lek Cesk; 2012; 151(2):76-82. PubMed ID: 22515013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymorphisms in prothrombotic genes in young stroke patients in Greece: a case-controlled study.
    Ranellou K; Paraskeva A; Kyriazopoulos P; Batistatou A; Evangelou A; El-Aly M; Zis P; Tavernarakis A; Charalabopoulos K
    Blood Coagul Fibrinolysis; 2015 Jun; 26(4):430-5. PubMed ID: 25699610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prospective case-control study analyzes 12 thrombophilic gene mutations in Turkish couples with recurrent pregnancy loss.
    Yenicesu GI; Cetin M; Ozdemir O; Cetin A; Ozen F; Yenicesu C; Yildiz C; Kocak N
    Am J Reprod Immunol; 2010 Feb; 63(2):126-36. PubMed ID: 19906129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic and acquired prothrombotic risk factors and sudden hearing loss.
    Capaccio P; Ottaviani F; Cuccarini V; Bottero A; Schindler A; Cesana BM; Censuales S; Pignataro L
    Laryngoscope; 2007 Mar; 117(3):547-51. PubMed ID: 17334320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of polymorphisms in factor V (FV Leiden), prothrombin, plasminogen activator inhibitor type-1 (PAI-1), methylenetetrahydrofolate reductase (MTHFR) and cystathionine β-synthase (CBS) genes as risk factors for thrombophilias.
    Miranda-Vilela AL
    Mini Rev Med Chem; 2012 Sep; 12(10):997-1006. PubMed ID: 22512572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primer-engineered multiplex PCR-RFLP for detection of MTHFR C677T, prothrombin G20210A and factor V Leiden mutations.
    Koksal V; Baris I; Etlik O
    Exp Mol Pathol; 2007 Aug; 83(1):1-3. PubMed ID: 17275807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of prothrombin G20210A, factor V G1691A (Leiden), and methylenetetrahydrofolate reductase (MTHFR) C677T in seven different populations determined by multiplex allele-specific PCR.
    Hessner MJ; Luhm RA; Pearson SL; Endean DJ; Friedman KD; Montgomery RR
    Thromb Haemost; 1999 May; 81(5):733-8. PubMed ID: 10365746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutations in clotting factors and inflammatory bowel disease.
    Bernstein CN; Sargent M; Vos HL; Rosendaal FR
    Am J Gastroenterol; 2007 Feb; 102(2):338-43. PubMed ID: 17156138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasminogen activator inhibitor-1, factor V, factor II and methylenetetrahydrofolate reductase polymorphisms in women with recurrent miscarriage.
    Pietropolli A; Giuliani E; Bruno V; Patrizi L; Piccione E; Ticconi C
    J Obstet Gynaecol; 2014 Apr; 34(3):229-34. PubMed ID: 24484533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factor V Leiden (G1691A), the prothrombin 3'-untranslated region variant (G20210A) and thermolabile methylenetetrahydrofolate reductase (C677T): a single genetic test genotypes all three loci--determination of frequencies in the S. Wales population of the UK.
    Bowen DJ; Bowley S; John M; Collins PW
    Thromb Haemost; 1998 May; 79(5):949-54. PubMed ID: 9609227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic polymorphisms associated with retinal vein occlusion: a Greek case-control study and meta-analysis.
    Yioti GG; Panagiotou OA; Vartholomatos GA; Kolaitis NI; Pappa CN; Evangelou E; Stefaniotou MI
    Ophthalmic Genet; 2013 Sep; 34(3):130-9. PubMed ID: 23289804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical impact of factor V Leiden, prothrombin G20210A, and MTHFR C677T mutations among sickle cell disease patients of Central India.
    Nishank SS; Singh MP; Yadav R
    Eur J Haematol; 2013 Nov; 91(5):462-6. PubMed ID: 23992124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.